litlas
ログインアカウント作成

Guido Gerken

1987–2022 年に発表

134
論文数
25,798
被引用数
94
h 指数
134
i10 指数

被引用数

Guido Gerken の年別被引用数1979 年: 被引用 1 件1983 年: 被引用 1 件1988 年: 被引用 1 件1989 年: 被引用 3 件1990 年: 被引用 5 件1991 年: 被引用 5 件1992 年: 被引用 20 件1993 年: 被引用 30 件1994 年: 被引用 42 件1995 年: 被引用 37 件1996 年: 被引用 33 件1997 年: 被引用 41 件1998 年: 被引用 49 件1999 年: 被引用 65 件2000 年: 被引用 79 件2001 年: 被引用 119 件2002 年: 被引用 114 件2003 年: 被引用 111 件2004 年: 被引用 128 件2005 年: 被引用 151 件2006 年: 被引用 160 件2007 年: 被引用 163 件2008 年: 被引用 183 件2009 年: 被引用 173 件2010 年: 被引用 205 件2011 年: 被引用 208 件2012 年: 被引用 233 件2013 年: 被引用 252 件2014 年: 被引用 264 件2015 年: 被引用 273 件2016 年: 被引用 239 件2017 年: 被引用 249 件2018 年: 被引用 217 件2019 年: 被引用 716 件2020 年: 被引用 802 件2021 年: 被引用 783 件2022 年: 被引用 614 件2023 年: 被引用 425 件2024 年: 被引用 539 件2025 年: 被引用 269 件2026 年: 被引用 6 件1980〜1982 年は被引用が無いため表示していません1984〜1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,296 件、この内訳の 21%中国: 引用元論文 1,345 件、この内訳の 12.3%ドイツ: 引用元論文 934 件、この内訳の 8.6%イタリア: 引用元論文 628 件、この内訳の 5.7%イギリス: 引用元論文 622 件、この内訳の 5.7%日本: 引用元論文 487 件、この内訳の 4.5%フランス: 引用元論文 461 件、この内訳の 4.2%スペイン: 引用元論文 368 件、この内訳の 3.4%カナダ: 引用元論文 316 件、この内訳の 2.9%オランダ: 引用元論文 285 件、この内訳の 2.6%オーストラリア: 引用元論文 273 件、この内訳の 2.5%韓国: 引用元論文 241 件、この内訳の 2.2%
0%21%その他 24.4%

機関

分野

  • Medicine71.6%
  • Biochemistry, Genetics and Molecular Biology14%
  • Immunology and Microbiology7.7%
  • Pharmacology, Toxicology and Pharmaceutics2.2%
  • Agricultural and Biological Sciences1.4%
  • Nursing0.8%
  • その他2.3%

トピック

  • Liver Disease Diagnosis and Treatment10%
  • Hepatocellular Carcinoma Treatment and Prognosis6.9%
  • Hepatitis B Virus Studies5.1%
  • Hepatitis C virus research4.6%
  • Liver Disease and Transplantation3.4%
  • Liver physiology and pathology2.6%
  • その他67.4%

共著者

全論文

検索で開く
  1. Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial

    著者: Andrew X. Zhu, Yoon‐Koo Kang, Chia‐Jui Yen, Richard S. Finn, Peter R. Galle, Josep M. Llovet, Eric Assénat, Giovanni Brandi, Marc Pracht, Ho Yeong Lim, Kun‐Ming Rau, Kenta Motomura, Izumi Ohno, Philippe Merle, Bruno Daniele, Dong Bok Shin, Guido Gerken, Christophe Borg, Jean‐Baptiste Hiriart, Takuji Okusaka, Manabu Morimoto, Yanzhi Hsu, Paolo Abada, Masatoshi Kudo - The Lancet Oncology 2019 被引用: 1,655

  2. The interaction of hepatic lipid and glucose metabolism in liver diseases

    著者: Lars P. Bechmann, Rebekka A. Hannivoort, Guido Gerken, Gökhan S. Hotamışlıgil, Michael Trauner, Ali Canbay - Journal of Hepatology 2011 被引用: 991

  3. GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis

    著者: Jan Best, Lars P. Bechmann, Jan‐Peter Sowa, Svenja Sydor, Alexander Dechêne, Kristina Pflanz, Sotiria Bedreli, Clemens Schotten, Andreas Geier, Thomas Berg, Janett Fischer, Arndt Vogel, Heike Bantel, Arndt Weinmann, Jörn M. Schattenberg, Yvonne Huber, Henning Wege, Johann von Felden, Kornelius Schulze, Dominik Bettinger, Robert Thimme, Friedrich Sinner, Kerstin Schütte, Karl Heinz Weiss, Hidenori Toyoda, Satoshi Yasuda, Takashi Kumada, Sarah Berhane, Marc Wichert, Dominik Heider, Guido Gerken, Philip J. Johnson, Ali Canbay - Clinical Gastroenterology and Hepatology 2019 被引用: 289

  4. Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients

    著者: Sarah Berhane, Hidenori Toyoda, Toshifumi Tada, Takashi Kumada, Chiaki Kagebayashi, Shinji Satomura, Nóra Schweitzer, Arndt Vogel, Michael P. Manns, Julia Benckert, Thomas Berg, Maria Ebker, Jan Best, Alexander Dechêne, Guido Gerken, JF Schlaak, Arndt Weinmann, Marcus A. Wörns, Peter R. Galle, Winnie Yeo, Frankie Mo, Stephen L. Chan, Helen L. Reeves, Trevor F. Cox, Philip J. Johnson - Clinical Gastroenterology and Hepatology 2016 被引用: 323

  5. Toll-Like Receptor 2 Controls Mucosal Inflammation by Regulating Epithelial Barrier Function

    著者: Elke Cario, Guido Gerken, Daniel K. Podolsky - Gastroenterology 2007 被引用: 683

  6. Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC

    著者: Svenja Sydor, Jan Best, I Messerschmidt, Paul Manka, Ramiro Vilchez‐Vargas, Susanne Brodesser, Christina Lucas, A Wegehaupt, C Wenning, S Aßmuth, Simon Hohenester, Alexander Link, Klaas Nico Faber, Han Moshage, Francisco Javier Cubero, Scott L. Friedman, Guido Gerken, Michael Trauner, Ali Canbay, Lars P. Bechmann - Clinical and Translational Gastroenterology 2020 被引用: 131

  7. Resminostat plus sorafenib as second-line therapy of advanced hepatocellular carcinoma – The SHELTER study

    著者: Michael Bitzer, Marius Horger, Edoardo G. Giannini, Tom M. Ganten, Marcus A. Wörns, Jens T. Siveke, Matthias Dollinger, Guido Gerken, M. E. Scheulen, Henning Wege, Vittorina Zagonel, Umberto Cillo, Franco Trevisani, Armando Santoro, Vincenzo Montesarchio, Nisar P. Malek, Julia Holzapfel, Thomas Herz, Astrid Ammendola, Stefano Pegoraro, Bernhard Hauns, Anna Mais, Ulrich M. Lauer, Stefan Henning, Bernd Hentsch - Journal of Hepatology 2016 被引用: 138

  8. Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

    著者: Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Vincenzo Mazzaferro, Luigi Bolondi, Antonio Craxı̀, Peter R. Galle, Armando Santoro, Michel Beaugrand, Angelo Sangiovanni, Camillo Porta, Guido Gerken, Jorge A. Marrero, Andrea Nadel, Michael Shan, M. Moscovici, D. Voliotis, Josep M. Llovet - Journal of Hepatology 2012 被引用: 821

  9. Effects of Fractionated Plasma Separation and Adsorption on Survival in Patients With Acute-on-Chronic Liver Failure

    著者: Andreas Kribben, Guido Gerken, Sebastian Haag, Stefan Herget‐Rosenthal, Ulrich Treichel, Christoph Betz, Christoph Sarrazin, Eric A. J. Hoste, Hans Van Vlierberghe, Àngels Escorsell, Carsten Hafer, Oliver Schreiner, Peter R. Galle, Elena Mancini, Paolo Caraceni, Constantine Karvellas, Hermann Salmhofer, Mladen Knotek, Pere Ginès, Justyna Kozik–Jaromin, Kinan Rifai - Gastroenterology 2012 被引用: 401

  10. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial

    著者: Harry L.A. Janssen, Monika van Zonneveld, Hakan Şentürk, Stefan Zeuzem, Ulus Salih Akarca, Yılmaz Çakaloğlu, Christopher Simon, Thomas M. K. So, Guido Gerken, Robert A. de Man, Hubert G.M. Niesters, Pieter E. Zondervan, Bettina E. Hansen, Solko W. Schalm - The Lancet 2005 被引用: 1,163

  11. Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis

    著者: Judith Ertle, Alexander Dechêne, Jan‐Peter Sowa, Volker Penndorf, Kerstin Herzer, Gernot Kaiser, JF Schlaak, Guido Gerken, Wing‐Kin Syn, Ali Canbay - International Journal of Cancer 2010 被引用: 521

  12. Toll-like receptor 2 enhances ZO-1-associated intestinal epithelial barrier integrity via protein kinase C

    著者: Elke Cario, Guido Gerken, Daniel K. Podolsky - Gastroenterology 2004 被引用: 473

  13. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis

    著者: Lars P. Bechmann, Peri Kocabayoglu, Jan‐Peter Sowa, Svenja Sydor, Jan Best, Martin Schlattjan, A Beilfuss, Johannes Schmitt, Rebekka A. Hannivoort, Alpaslan Kılıçarslan, Christian Rust, Frieder Berr, Oliver Tschopp, Guido Gerken, Scott L. Friedman, Andreas Geier, Ali Canbay - Hepatology 2013 被引用: 231

  14. Small Bowel Homing T Cells Are Associated With Symptoms and Delayed Gastric Emptying in Functional Dyspepsia

    著者: Tobias Liebregts, Birgit Adam, Christoph Bredack, Montri Gururatsakul, Katherine R. Pilkington, Stuart M. Brierley, L. Ashley Blackshaw, Guido Gerken, Nicholas J. Talley, Gerald Holtmann - The American Journal of Gastroenterology 2011 被引用: 194

  15. Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently

    著者: A Beilfuss, Jan‐Peter Sowa, Svenja Sydor, Mechthild Beste, Lars P. Bechmann, Martin Schlattjan, Wing‐Kin Syn, Inga Wedemeyer, Zoltán Máthé, Christoph Jochum, Guido Gerken, Robert K. Gieseler, Ali Canbay - Gut 2014 被引用: 155

  16. Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study

    著者: Armando Santoro, Lorenza Rimassa, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean‐Luc Van Laethem, Hans Van Vlierberghe, Jörg Trojan, Frank T. Kolligs, Alan Weiss, Steven A. Miles, Antonio Gasbarrini, Monica Lencioni, Luca Cicalese, Morris Sherman, Cesare Gridelli, Peter Buggisch, Guido Gerken, Roland M. Schmid, C. Boni, Nicola Personeni, Ziad Hassoun, Giovanni Abbadessa, Brian Schwartz, Reinhard von Roemeling, Maria Lamar, Yinpu Chen, Camillo Porta - The Lancet Oncology 2012 被引用: 550

  17. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?

    著者: Amr El Fouly, Judith Ertle, Ahmed El Dorry, Mohamed Shaker, Alexander Dechêne, Heba Mohamed Abdella, Stefan Müeller, Eman Barakat, Thomas C. Lauenstein, Andreas Bockisch, Guido Gerken, JF Schlaak - Liver International 2014 被引用: 125

  18. Radioembolization with Yttrium-90 Glass Microspheres in Hepatocellular Carcinoma: European Experience on Safety and Long-Term Survival

    著者: Philip Hilgard, M Hamami, Amr El Fouly, André Scherag, Stefan Müller, Judith Ertle, Till A. Heusner, Vito R. Cicinnati, Andreas Paul, Andreas Bockisch, Guido Gerken, Gerald Antoch - Hepatology 2010 被引用: 452

  19. Induction of cytokine production in naive CD4+ T cells by antigen-presenting murine liver sinusoidal endothelial cells but failure to induce differentiation toward Th1 cells☆, ☆☆

    著者: Percy A. Knolle, Edgar Schmitt, Shu-Gen Jin, Tieno Germann, Rainer Duchmann, Silke Hegenbarth, Guido Gerken, AW Lohse - Gastroenterology 1999 被引用: 299

  20. Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific

    著者: Jun Wu, Zhongji Meng, Min Jiang, Ejuan Zhang, Martin Trippler, Ruth Broering, Agnes Bucchi, Frank Krux, Ulf Dittmer, Dongliang Yang, Michael Roggendorf, Guido Gerken, Mengji Lu, JF Schlaak - Immunology 2009 被引用: 210

  21. Serum alpha-fetoprotein and clinical outcomes in patients with advanced hepatocellular carcinoma treated with ramucirumab

    著者: Andrew X. Zhu, Richard S. Finn, Yoon‐Koo Kang, Chia-Jui Yen, Peter R. Galle, Josep M. Llovet, Eric Assénat, Giovanni Brandi, Kenta Motomura, Izumi Ohno, Bruno Daniele, Arndt Vogel, Tatsuya Yamashita, Chih‐Hung Hsu, Guido Gerken, John Bilbruck, Yanzhi Hsu, Kun Liang, Ryan C. Widau, Chunxiao Wang, Paolo Abada, Masatoshi Kudo - British Journal of Cancer 2021 被引用: 66

  22. Hepatitis B virus suppresses toll-like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells #

    著者: Jun Wu, Zhongji Meng, Min Jiang, Rongjuan Pei, Martin Trippler, Ruth Broering, Agnes Bucchi, Jan‐Peter Sowa, Ulf Dittmer, Dongliang Yang, Michael Roggendorf, Guido Gerken, Mengji Lu, JF Schlaak - Hepatology 2008 被引用: 315

  23. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver

    著者: A Uhrig, Ramin Banafsche, Michael Kremer, Silke Hegenbarth, Alf Hamann, Markus F. Neurath, Guido Gerken, Andreas Limmer, Percy A. Knolle - Journal of Leukocyte Biology 2005 被引用: 164

  24. Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge

    著者: P Knöll, JF Schlaak, A Uhrig, P. Kempf, Karl‐Hermann Meyer zum Büschenfelde, Guido Gerken - Journal of Hepatology 1995 被引用: 381